ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Biological Products Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-4X8287
Home | Market Reports | Health| Pharmacy
Global and China Blood Biological Products Market Insights Forecast to 2027
BUY CHAPTERS

Global Blood Biological Products Market Research Report 2025

Code: QYRE-Auto-4X8287
Report
July 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
CSL Limited
Grifols S A
Octapharma AG
Kedrion S p A
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Blood Biological Products Market Size

The global market for Blood Biological Products was valued at US$ 34940 million in the year 2024 and is projected to reach a revised size of US$ 57930 million by 2031, growing at a CAGR of 7.6% during the forecast period.

Blood Biological Products Market

Blood Biological Products Market

Human blood plasma is nature"s raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.
This report aims to provide a comprehensive presentation of the global market for Blood Biological Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Biological Products.
The Blood Biological Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Biological Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Biological Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Blood Biological Products Market Report

Report Metric Details
Report Name Blood Biological Products Market
Accounted market size in year US$ 34940 million
Forecasted market size in 2031 US$ 57930 million
CAGR 7.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Immunology
  • Hematology
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Blood Biological Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Biological Products Market growing?

Ans: The Blood Biological Products Market witnessing a CAGR of 7.6% during the forecast period 2025-2031.

What is the Blood Biological Products Market size in 2031?

Ans: The Blood Biological Products Market size in 2031 will be US$ 57930 million.

Who are the main players in the Blood Biological Products Market report?

Ans: The main players in the Blood Biological Products Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Blood Biological Products Market report?

Ans: The Applications covered in the Blood Biological Products Market report are Immunology, Hematology, Other

What are the Type segmentation covered in the Blood Biological Products Market report?

Ans: The Types covered in the Blood Biological Products Market report are Coagulation Factor, Immune Globulin, Albumin, Other

Recommended Reports

Blood Products

Blood Collection

Plasma Fractionation

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Biological Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Blood Biological Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Biological Products Market Perspective (2020-2031)
2.2 Global Blood Biological Products Growth Trends by Region
2.2.1 Global Blood Biological Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blood Biological Products Historic Market Size by Region (2020-2025)
2.2.3 Blood Biological Products Forecasted Market Size by Region (2026-2031)
2.3 Blood Biological Products Market Dynamics
2.3.1 Blood Biological Products Industry Trends
2.3.2 Blood Biological Products Market Drivers
2.3.3 Blood Biological Products Market Challenges
2.3.4 Blood Biological Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Biological Products Players by Revenue
3.1.1 Global Top Blood Biological Products Players by Revenue (2020-2025)
3.1.2 Global Blood Biological Products Revenue Market Share by Players (2020-2025)
3.2 Global Blood Biological Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blood Biological Products Revenue
3.4 Global Blood Biological Products Market Concentration Ratio
3.4.1 Global Blood Biological Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Biological Products Revenue in 2024
3.5 Global Key Players of Blood Biological Products Head office and Area Served
3.6 Global Key Players of Blood Biological Products, Product and Application
3.7 Global Key Players of Blood Biological Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Biological Products Breakdown Data by Type
4.1 Global Blood Biological Products Historic Market Size by Type (2020-2025)
4.2 Global Blood Biological Products Forecasted Market Size by Type (2026-2031)
5 Blood Biological Products Breakdown Data by Application
5.1 Global Blood Biological Products Historic Market Size by Application (2020-2025)
5.2 Global Blood Biological Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blood Biological Products Market Size (2020-2031)
6.2 North America Blood Biological Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blood Biological Products Market Size by Country (2020-2025)
6.4 North America Blood Biological Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Biological Products Market Size (2020-2031)
7.2 Europe Blood Biological Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blood Biological Products Market Size by Country (2020-2025)
7.4 Europe Blood Biological Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Biological Products Market Size (2020-2031)
8.2 Asia-Pacific Blood Biological Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blood Biological Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Blood Biological Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Biological Products Market Size (2020-2031)
9.2 Latin America Blood Biological Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blood Biological Products Market Size by Country (2020-2025)
9.4 Latin America Blood Biological Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Biological Products Market Size (2020-2031)
10.2 Middle East & Africa Blood Biological Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blood Biological Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Blood Biological Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Blood Biological Products Introduction
11.1.4 Takeda Revenue in Blood Biological Products Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Blood Biological Products Introduction
11.2.4 CSL Revenue in Blood Biological Products Business (2020-2025)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Blood Biological Products Introduction
11.3.4 Grifols Revenue in Blood Biological Products Business (2020-2025)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Blood Biological Products Introduction
11.4.4 Octapharma Revenue in Blood Biological Products Business (2020-2025)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Blood Biological Products Introduction
11.5.4 Kedrion Revenue in Blood Biological Products Business (2020-2025)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Blood Biological Products Introduction
11.6.4 LFB Group Revenue in Blood Biological Products Business (2020-2025)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Blood Biological Products Introduction
11.7.4 Biotest Revenue in Blood Biological Products Business (2020-2025)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Blood Biological Products Introduction
11.8.4 BPL Revenue in Blood Biological Products Business (2020-2025)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Blood Biological Products Introduction
11.9.4 RAAS Revenue in Blood Biological Products Business (2020-2025)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Blood Biological Products Introduction
11.10.4 CBPO Revenue in Blood Biological Products Business (2020-2025)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Blood Biological Products Introduction
11.11.4 Hualan Bio Revenue in Blood Biological Products Business (2020-2025)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Details
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Blood Biological Products Introduction
11.12.4 Tiantan Bio Revenue in Blood Biological Products Business (2020-2025)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Details
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Blood Biological Products Introduction
11.13.4 Shuanglin Bio Revenue in Blood Biological Products Business (2020-2025)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Details
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Blood Biological Products Introduction
11.14.4 Boya Bio Revenue in Blood Biological Products Business (2020-2025)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Details
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Blood Biological Products Introduction
11.15.4 Yuanda Shuyang Revenue in Blood Biological Products Business (2020-2025)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Details
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Blood Biological Products Introduction
11.16.4 Weiguang Bio Revenue in Blood Biological Products Business (2020-2025)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Details
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Blood Biological Products Introduction
11.17.4 Nanyue Bio Revenue in Blood Biological Products Business (2020-2025)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Details
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Blood Biological Products Introduction
11.18.4 KM Biologics Revenue in Blood Biological Products Business (2020-2025)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Takeda
CSL Limited
Grifols S A
Octapharma AG
Kedrion S p A
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
List of Tables
 Table 1. Global Blood Biological Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Coagulation Factor
 Table 3. Key Players of Immune Globulin
 Table 4. Key Players of Albumin
 Table 5. Key Players of Other
 Table 6. Global Blood Biological Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Blood Biological Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Blood Biological Products Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Blood Biological Products Market Share by Region (2020-2025)
 Table 10. Global Blood Biological Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Blood Biological Products Market Share by Region (2026-2031)
 Table 12. Blood Biological Products Market Trends
 Table 13. Blood Biological Products Market Drivers
 Table 14. Blood Biological Products Market Challenges
 Table 15. Blood Biological Products Market Restraints
 Table 16. Global Blood Biological Products Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Blood Biological Products Market Share by Players (2020-2025)
 Table 18. Global Top Blood Biological Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Biological Products as of 2024)
 Table 19. Ranking of Global Top Blood Biological Products Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Blood Biological Products Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Blood Biological Products, Headquarters and Area Served
 Table 22. Global Key Players of Blood Biological Products, Product and Application
 Table 23. Global Key Players of Blood Biological Products, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Blood Biological Products Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Blood Biological Products Revenue Market Share by Type (2020-2025)
 Table 27. Global Blood Biological Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Blood Biological Products Revenue Market Share by Type (2026-2031)
 Table 29. Global Blood Biological Products Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Blood Biological Products Revenue Market Share by Application (2020-2025)
 Table 31. Global Blood Biological Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Blood Biological Products Revenue Market Share by Application (2026-2031)
 Table 33. North America Blood Biological Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Blood Biological Products Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Blood Biological Products Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Blood Biological Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Blood Biological Products Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Blood Biological Products Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Blood Biological Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Blood Biological Products Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Blood Biological Products Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Blood Biological Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Blood Biological Products Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Blood Biological Products Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Blood Biological Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Blood Biological Products Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Blood Biological Products Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Takeda Company Details
 Table 49. Takeda Business Overview
 Table 50. Takeda Blood Biological Products Product
 Table 51. Takeda Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 52. Takeda Recent Development
 Table 53. CSL Company Details
 Table 54. CSL Business Overview
 Table 55. CSL Blood Biological Products Product
 Table 56. CSL Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 57. CSL Recent Development
 Table 58. Grifols Company Details
 Table 59. Grifols Business Overview
 Table 60. Grifols Blood Biological Products Product
 Table 61. Grifols Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 62. Grifols Recent Development
 Table 63. Octapharma Company Details
 Table 64. Octapharma Business Overview
 Table 65. Octapharma Blood Biological Products Product
 Table 66. Octapharma Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 67. Octapharma Recent Development
 Table 68. Kedrion Company Details
 Table 69. Kedrion Business Overview
 Table 70. Kedrion Blood Biological Products Product
 Table 71. Kedrion Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 72. Kedrion Recent Development
 Table 73. LFB Group Company Details
 Table 74. LFB Group Business Overview
 Table 75. LFB Group Blood Biological Products Product
 Table 76. LFB Group Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 77. LFB Group Recent Development
 Table 78. Biotest Company Details
 Table 79. Biotest Business Overview
 Table 80. Biotest Blood Biological Products Product
 Table 81. Biotest Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 82. Biotest Recent Development
 Table 83. BPL Company Details
 Table 84. BPL Business Overview
 Table 85. BPL Blood Biological Products Product
 Table 86. BPL Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 87. BPL Recent Development
 Table 88. RAAS Company Details
 Table 89. RAAS Business Overview
 Table 90. RAAS Blood Biological Products Product
 Table 91. RAAS Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 92. RAAS Recent Development
 Table 93. CBPO Company Details
 Table 94. CBPO Business Overview
 Table 95. CBPO Blood Biological Products Product
 Table 96. CBPO Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 97. CBPO Recent Development
 Table 98. Hualan Bio Company Details
 Table 99. Hualan Bio Business Overview
 Table 100. Hualan Bio Blood Biological Products Product
 Table 101. Hualan Bio Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 102. Hualan Bio Recent Development
 Table 103. Tiantan Bio Company Details
 Table 104. Tiantan Bio Business Overview
 Table 105. Tiantan Bio Blood Biological Products Product
 Table 106. Tiantan Bio Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 107. Tiantan Bio Recent Development
 Table 108. Shuanglin Bio Company Details
 Table 109. Shuanglin Bio Business Overview
 Table 110. Shuanglin Bio Blood Biological Products Product
 Table 111. Shuanglin Bio Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 112. Shuanglin Bio Recent Development
 Table 113. Boya Bio Company Details
 Table 114. Boya Bio Business Overview
 Table 115. Boya Bio Blood Biological Products Product
 Table 116. Boya Bio Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 117. Boya Bio Recent Development
 Table 118. Yuanda Shuyang Company Details
 Table 119. Yuanda Shuyang Business Overview
 Table 120. Yuanda Shuyang Blood Biological Products Product
 Table 121. Yuanda Shuyang Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 122. Yuanda Shuyang Recent Development
 Table 123. Weiguang Bio Company Details
 Table 124. Weiguang Bio Business Overview
 Table 125. Weiguang Bio Blood Biological Products Product
 Table 126. Weiguang Bio Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 127. Weiguang Bio Recent Development
 Table 128. Nanyue Bio Company Details
 Table 129. Nanyue Bio Business Overview
 Table 130. Nanyue Bio Blood Biological Products Product
 Table 131. Nanyue Bio Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 132. Nanyue Bio Recent Development
 Table 133. KM Biologics Company Details
 Table 134. KM Biologics Business Overview
 Table 135. KM Biologics Blood Biological Products Product
 Table 136. KM Biologics Revenue in Blood Biological Products Business (2020-2025) & (US$ Million)
 Table 137. KM Biologics Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Blood Biological Products Picture
 Figure 2. Global Blood Biological Products Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Blood Biological Products Market Share by Type: 2024 VS 2031
 Figure 4. Coagulation Factor Features
 Figure 5. Immune Globulin Features
 Figure 6. Albumin Features
 Figure 7. Other Features
 Figure 8. Global Blood Biological Products Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Blood Biological Products Market Share by Application: 2024 VS 2031
 Figure 10. Immunology Case Studies
 Figure 11. Hematology Case Studies
 Figure 12. Other Case Studies
 Figure 13. Blood Biological Products Report Years Considered
 Figure 14. Global Blood Biological Products Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Blood Biological Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Blood Biological Products Market Share by Region: 2024 VS 2031
 Figure 17. Global Blood Biological Products Market Share by Players in 2024
 Figure 18. Global Top Blood Biological Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Biological Products as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Blood Biological Products Revenue in 2024
 Figure 20. North America Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Blood Biological Products Market Share by Country (2020-2031)
 Figure 22. United States Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Blood Biological Products Market Share by Country (2020-2031)
 Figure 26. Germany Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Blood Biological Products Market Share by Region (2020-2031)
 Figure 34. China Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Blood Biological Products Market Share by Country (2020-2031)
 Figure 42. Mexico Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Blood Biological Products Market Share by Country (2020-2031)
 Figure 46. Turkey Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Blood Biological Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Takeda Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 50. CSL Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 51. Grifols Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 52. Octapharma Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 53. Kedrion Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 54. LFB Group Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 55. Biotest Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 56. BPL Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 57. RAAS Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 58. CBPO Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 59. Hualan Bio Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 60. Tiantan Bio Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 61. Shuanglin Bio Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 62. Boya Bio Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 63. Yuanda Shuyang Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 64. Weiguang Bio Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 65. Nanyue Bio Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 66. KM Biologics Revenue Growth Rate in Blood Biological Products Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Human Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma Fractionation and Blood Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Plasma Products and Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fractionated Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma derived Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma Fractionation Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma for Fractionation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Plasma Fractionation Product Market Research Report 2024
Global Human Plasma Protein Products Market Research Report 2024
Global Plasma derived Medical Product Market Research Report 2025
Global Blood Plasma Fractionation Market Research Report 2025
Global Human Blood Plasma Fractionation Market Research Report 2025
Global Plasma Fractionation Market Research Report 2025
Global Blood Plasma Fractionation Technology Market Research Report 2025
Global Plasma Fractionation Technology Market Research Report 2025
Global Blood Product Market Insights Forecast to 2030
Global Plasma Protein Therapeutics Market Research Report 2025
Global Blood Banking and Blood Products Market Research Report 2024
Blood Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Blood Products Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions